Ohemo Life Drug Patent Portfolio
Ohemo Life owns 1 orange book drug protected by 2 US patents Given below is the list of Ohemo Life's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10314788 | Pharmaceutical compositions configured to deter dosage form splitting | 12 Aug, 2028 | Active |
| US7955619 | Abuse resistant drugs, method of use and method of making | 12 Aug, 2028 | Active |
Latest Legal Activities on Ohemo Life's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ohemo Life.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Correspondence Address Change
Critical
| 21 Dec, 2023 | US7955619 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Jun, 2022 | US10314788 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 08 Jun, 2022 | US7955619 |
|
Email Notification
Critical
| 20 Oct, 2020 | US7955619 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 20 Oct, 2020 | US7955619 |
|
Correspondence Address Change
Critical
| 15 Oct, 2020 | US7955619 |
|
Email Notification
Critical
| 08 Sep, 2020 | US10314788 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 08 Sep, 2020 | US10314788 |
|
Correspondence Address Change
Critical
| 03 Sep, 2020 | US10314788 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 27 Aug, 2020 | US7955619 |
|
Email Notification
Critical
| 27 Aug, 2020 | US7955619 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Aug, 2020 | US10314788 |
|
Email Notification
Critical
| 26 Aug, 2020 | US10314788 |
| Mail O.P. Petition Decision | 28 Apr, 2020 | US10314788 |
|
Email Notification
Critical
| 28 Apr, 2020 | US10314788 |
Ohemo Life's Family Patents
Ohemo Life Drug List
Given below is the complete list of Ohemo Life's drugs and the patents protecting them.
1. Morphabond Er
Morphabond Er is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10314788 | Pharmaceutical compositions configured to deter dosage form splitting |
12 Aug, 2028
(3 years from now)
| Active |
| US7955619 | Abuse resistant drugs, method of use and method of making |
12 Aug, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Morphabond Er's drug page